CM
NVAX icon

Caption Management’s Novavax NVAX Stock Holding History

Caption Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-148,155
Closed -$1.33M – 1930
2026
Q1 		$1.21M Buy
148,155
+9,105
+7% +$82.5K 0.01% 960
2025
Q4 		$934K Buy
+139,050
New +$1.05M 0.01% 1080
2025
Q2 		– Sell
-94,345
Closed -$625K – 1757
2025
Q1 		$605K Buy
+94,345
New +$780K 0.01% 1053
2024
Q3 		– Sell
-12,000
Closed -$155K – 1498
2024
Q2 		$152K Sell
12,000
-9,698
-45% -$97.6K ﹤0.01% 987
2024
Q1 		$104K Buy
+21,698
New +$101K ﹤0.01% 1055
2021
Q2 		– Sell
-7,700
Closed -$1.4M – 1495
2021
Q1 		$1.4M Buy
+7,700
New +$1.53M 0.03% 611
2019
Q1 		– Sell
-29,500
Closed -$931K – 687
2018
Q4 		$1.08M Buy
+29,500
New +$1.14M 0.09% 254

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Caption Management's NVAX Position: Q2 2026 in Review

Caption Management sold out of Novavax (NVAX) in Q2 2026, closing a stake of 148,155 shares — an estimated $1.33M sold.

Caption Management first reported a position in NVAX in Q4 2018 and held it in 7 quarters. The position peaked at $1.4M in Q1 2021. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Caption Management reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 148,155 Novavax shares in Q2 2026, an estimated $1.33M.
  • Caption Management first reported a position in Novavax in Q4 2018 and held it in 7 quarters.
  • Caption Management's Novavax position peaked at $1.4M in Q1 2021.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.